English  |  正體中文  |  简体中文  |  總筆數 :2853327  
造訪人次 :  44987611    線上人數 :  1677
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"wu j y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 286-310 / 599 (共24頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-10-23T11:55:05Z No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families Wu J.-Y.; Hung S.-I.; Chen W.J.; Chueh C.-M.; Liu W.-M.; Liu C.-C.; Hsieh M.-H.; TZUNG-JENG HWANG; Faraone S.V.; Tsuang M.T.; Hwu H.-G.; Liu C.-M.; Liu Y.-L.; Fann C.S.-J.; Yang W.-C.
臺大學術典藏 2020-10-23T11:55:04Z RASD2, MYH9, and CACNG2 Genes at Chromosome 22q12 Associated with the Subgroup of Schizophrenia with Non-Deficit in Sustained Attention and Executive Function Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Chen W.J.; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Jou Y.-S.; Liu S.-K.; TZUNG-JENG HWANG; Hsieh M.H.; Chang C.C.; Yang W.-C.; Lin J.-J.; Chou F.H.-C.; Faraone S.V.; Tsuang M.T.; Hwu H.-G.
臺大學術典藏 2020-10-23T11:55:04Z HTF9C gene of 22q11.21 region associates with schizophrenia having deficit-sustained attention Liu Y.-L.;Fann C.S.-J.;Liu C.-M.;Ching Chang C.;Yang W.-C.;Wu J.-Y.;Hung S.-I.;Chan H.-Y.;Chen J.-J.;Hsieh M.H.;Tzung-Jeng Hwang;Faraone S.V.;Tsuang M.T.;Chen W.J.;Hwu H.-G.;Chung-Shan; Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; Ching Chang C.; Yang W.-C.; Wu J.-Y.; Hung S.-I.; Chan H.-Y.; Chen J.-J.; Hsieh M.H.; TZUNG-JENG HWANG; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G.; Chung-Shan
臺大學術典藏 2020-10-23T11:55:04Z More evidence supports the association of PPP3CC with schizophrenia Liu Y.L.; Fann C.S.J.; Liu C.M.; Chang C.C.; Yang W.C.; Hung S.I.; Yu S.L.; Hwang T.J.; Hsieh M.H.; Liu C.C.; Tsuang M.M.; Wu J.Y.; Jou Y.S.; Faraone S.V.; Tsuang M.T.; Chen W.J.; Hwu H.-G.
臺大學術典藏 2020-10-23T11:55:03Z Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p Faraone S.V.; Tsuang M.T.; Hwu H.-G.; Chen W.J.; Lin S.-H.; Liu C.-M.; Liu Y.-L.; Shen-Jang Fann C.; Hsiao P.-C.; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Wu H.-M.; Jou Y.-S.; Liu S.K.; Chou F.H.-C.; Hwang T.J.; Hsieh M.H.; Chang C.-C.; Yang W.-C.; Lin J.-J.
臺大學術典藏 2020-08-13T06:34:02Z Leg pains, clubbing of digits and lung mass: What is your call? Wu J.-Y.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:34:00Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.
臺大學術典藏 2020-08-13T06:33:58Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer JIN-YUAN SHIH; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; Yang P.-C.; Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Yang P.-C.
臺大學術典藏 2020-08-13T06:33:57Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; JIN-YUAN SHIH; Yang P.-C.; Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Jin-Yuan Shih;Yang P.-C.
臺大學術典藏 2020-08-13T06:33:53Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J.
臺大學術典藏 2020-08-13T06:33:53Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:52Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:38Z Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer JIN-YUAN SHIH; Wu J.-Y.
臺大學術典藏 2020-08-13T06:33:25Z Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations Wu J.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏 2020-08-12T08:25:31Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang C.-H.; SHANG-GIN WU; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:31Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern SHANG-GIN WU; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:31Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:30Z Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection Yang P.-C.; Kuo P.-H.; Wu J.-Y.; SHANG-GIN WU; Sun H.-Y.
臺大學術典藏 2020-08-12T08:25:26Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU
臺大學術典藏 2020-08-12T06:35:29Z Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer Wu J.-Y.;Chong-Jen Yu;Shih J.-Y.;Yang C.-H.;Yang P.-C.; Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-08-12T06:35:23Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Yang P.-C.; Wu J.-Y.;Shih J.-Y.;Chen K.-Y.;Yang C.-H.;Chong-Jen Yu;Yang P.-C.; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU
臺大學術典藏 2020-08-12T06:35:22Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.;Chong-Jen Yu;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Yang P.-C.; Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T06:35:14Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU
臺大學術典藏 2020-08-12T06:35:08Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; Chang Y.-L.; Hu F.-C.; Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Chong-Jen Yu;Chang Y.-C.;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G.
臺大學術典藏 2020-08-12T02:50:56Z Adrenal insufficiency in prolonged critical illness Wu J.-Y.;Hsu S.-C.;Ku S.-C.;Chao-Chi Ho;Yu C.-J.;Yang P.-C.; Yang P.-C.; Wu J.-Y.; Hsu S.-C.; Ku S.-C.; CHAO-CHI HO; Yu C.-J.

顯示項目 286-310 / 599 (共24頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目